Kopanos, S., Filippatos, C., Rousakis, P., Kostopoulos, I. V., Baxevanis, C. N., Tentolouris, A., . . . Ntanasis-Stathopoulos, I. (2025). Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Cancers, 17(22), 3675. https://doi.org/10.3390/cancers17223675
Chicago Style (17th ed.) CitationKopanos, Stylianos, Charalampos Filippatos, Pantelis Rousakis, Ioannis V. Kostopoulos, Constantin N. Baxevanis, Anastasios Tentolouris, Maria Gavriatopoulou, Ourania Tsitsilonis, and Ioannis Ntanasis-Stathopoulos. "Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis." Cancers 17, no. 22 (2025): 3675. https://doi.org/10.3390/cancers17223675.
MLA (9th ed.) CitationKopanos, Stylianos, et al. "Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis." Cancers, vol. 17, no. 22, 2025, p. 3675, https://doi.org/10.3390/cancers17223675.
